EP1351930A4 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number: EP1351930A4
Authority: EP; European Patent Office
Prior art keywords: protease inhibitors; protease; inhibitors
Prior art date: 1999-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00977056A

Other languages

German (de)

French (fr)

Other versions

EP1351930A2 (en

Inventor

Robert W Marquis Jr

Daniel Frank Veber

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-10

Filing date

2000-11-08

Publication date

2004-09-15

2000-11-08 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2003-10-15 Publication of EP1351930A2 publication Critical patent/EP1351930A2/en

2004-09-15 Publication of EP1351930A4 publication Critical patent/EP1351930A4/en

Status Withdrawn legal-status Critical Current

Links

229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
239000000137 peptide hydrolase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

EP00977056A 1999-11-10 2000-11-08 Protease inhibitors Withdrawn EP1351930A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US16456199P	1999-11-10	1999-11-10
US164561P		1999-11-10
PCT/US2000/030682 WO2001034566A2 (en)	1999-11-10	2000-11-08	Protease inhibitors

Publications (2)

Publication Number	Publication Date
EP1351930A2 EP1351930A2 (en)	2003-10-15
EP1351930A4 true EP1351930A4 (en)	2004-09-15

Family

ID=22595065

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00977056A Withdrawn EP1351930A4 (en)	1999-11-10	2000-11-08	Protease inhibitors

Country Status (4)

Country	Link
EP (1)	EP1351930A4 (en)
JP (1)	JP2003533432A (en)
AU (1)	AU1474701A (en)
WO (1)	WO2001034566A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030144175A1 (en)	1998-12-23	2003-07-31	Smithkline Beecham Corporation	Protease inhibitors
TR200101869T2 (en) *	1998-12-23	2002-01-21	Smithkline Beecham Corporation	Protease Inhibitors.
EP1232155A4 (en)	1999-11-10	2002-11-20	Smithkline Beecham Corp	Protease inhibitors
WO2001034600A1 (en)	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
EP1229914A4 (en)	1999-11-10	2004-06-23	Smithkline Beecham Corp	Protease inhibitors
NZ520588A (en)	2000-03-21	2004-06-25	Smithkline Beecham Corp	Protease inhibitors
CO5280093A1 (en) *	2000-04-18	2003-05-30	Smithkline Beecham Corp	TREATMENT METHODS
CN105288305A (en) *	2015-11-30	2016-02-03	延欣虹	Pharmaceutical composition for curing oral excessive inflammation and gingival pain and swelling and preparation method of pharmaceutical composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998005336A1 (en) *	1996-08-08	1998-02-12	Smithkline Beecham Corporation	Inhibitors of cysteine protease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR200101869T2 (en) *	1998-12-23	2002-01-21	Smithkline Beecham Corporation	Protease Inhibitors.

2000
- 2000-11-08 EP EP00977056A patent/EP1351930A4/en not_active Withdrawn
- 2000-11-08 AU AU14747/01A patent/AU1474701A/en not_active Abandoned
- 2000-11-08 JP JP2001536515A patent/JP2003533432A/en not_active Withdrawn
- 2000-11-08 WO PCT/US2000/030682 patent/WO2001034566A2/en not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998005336A1 (en) *	1996-08-08	1998-02-12	Smithkline Beecham Corporation	Inhibitors of cysteine protease

Also Published As

Publication number	Publication date
AU1474701A (en)	2001-06-06
WO2001034566A2 (en)	2001-05-17
EP1351930A2 (en)	2003-10-15
JP2003533432A (en)	2003-11-11
WO2001034566A3 (en)	2003-07-31

Legal Events

Date	Code	Title	Description
2003-08-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-10-15	17P	Request for examination filed	Effective date: 20020603
2003-10-15	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-09-15	A4	Supplementary search report drawn up and despatched	Effective date: 20040729
2005-03-11	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-04-27	18D	Application deemed to be withdrawn	Effective date: 20041012

Publication	Publication Date	Title
PL349192A1 (en)	2002-07-01	Protease inhibitors
IL146518A0 (en)	2002-07-25	Metalloprotease inhibitors
AU4344101A (en)	2001-10-03	Protease inhibitors
EP1093367A4 (en)	2003-03-05	Protease inhibitors
PL350452A1 (en)	2002-12-16	Dihetero-substituted metalloprotease inhibitors
EP1067894A4 (en)	2004-09-08	Protease inhibitors
EP1235577A4 (en)	2003-04-09	Protease inhibitors
EP1079821A4 (en)	2001-08-29	Protease inhibitors
IL153421A0 (en)	2003-07-06	Protease inhibitors
EP1232155A4 (en)	2002-11-20	Protease inhibitors
EP1229912A4 (en)	2003-05-07	Protease inhibitors
EP1229915A4 (en)	2003-05-14	Protease inhibitors
EP1231921A4 (en)	2004-06-23	Protease inhibitors
EP1229914A4 (en)	2004-06-23	Protease inhibitors
HK1041690A1 (en)	2002-07-19	Protease inhibitors
EP1086083A4 (en)	2001-09-26	Protease inhibitors
IL151087A0 (en)	2003-04-10	Protease inhibitors
HK1043534A1 (en)	2002-09-20	Protease inhibitors
EP1233771A4 (en)	2003-05-14	Protease inhibitors
HK1044758A1 (en)	2002-11-01	Protease inhibitors
EP1229911A4 (en)	2003-05-07	Protease inhibitors
EP1351930A4 (en)	2004-09-15	Protease inhibitors
EP1231923A4 (en)	2003-05-14	Protease inhibitors
EP1231922A4 (en)	2004-06-23	Protease inhibitors
EP1232154A4 (en)	2004-06-23	Protease inhibitors